Hyderabad study finds new way to tackle fungal infections
The story in brief
Scientists at CSIR-CCMB in Hyderabad identified two compounds that block 'Candida albicans' from changing shape, keeping it in a harmless form. The study, led by a collaboration with BRIC-Translational Health Science and Technology Institute, found glycolysis controls this morphogenesis, allowing the fungus to evade immune defences. The compounds could complement existing antifungal treatments, with further studies needed to evaluate their effectiveness and safety.